CENPVL1
gene geneOn this page
Also known as PRR6L1
Summary
CENPVL1 (centromere protein V like 1, HGNC:31851) is a protein-coding gene on chromosome Xp11.22, encoding Centromere protein V-like protein 1 (A0A0U1RR11).
Predicted to enable carbon-sulfur lyase activity and metal ion binding activity.
Source: NCBI Gene 389857 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 5 total
- MANE Select transcript:
NM_001355277
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:31851 |
| Approved symbol | CENPVL1 |
| Name | centromere protein V like 1 |
| Location | Xp11.22 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | PRR6L1 |
| Ensembl gene | ENSG00000223591 |
| Ensembl biotype | protein_coding |
| Entrez | 389857 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000602548
RefSeq mRNA: 1 — MANE Select: NM_001355277
NM_001355277
CCDS: CCDS87745
Canonical transcript exons
ENST00000602548 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003264129 | 51710512 | 51712131 |
Expression profiles
Bgee: expression breadth broad, 24 present calls, max score 59.05.
Top tissues by expression
123 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 59.05 | silver quality |
| ventricular zone | UBERON:0003053 | 58.76 | silver quality |
| putamen | UBERON:0001874 | 57.11 | gold quality |
| hypothalamus | UBERON:0001898 | 55.57 | gold quality |
| nucleus accumbens | UBERON:0001882 | 54.78 | gold quality |
| caudate nucleus | UBERON:0001873 | 54.53 | gold quality |
| temporal lobe | UBERON:0001871 | 47.43 | gold quality |
| amygdala | UBERON:0001876 | 47.39 | gold quality |
| gall bladder | UBERON:0002110 | 45.70 | gold quality |
| substantia nigra | UBERON:0002038 | 45.16 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 44.52 | gold quality |
| brain | UBERON:0000955 | 44.07 | gold quality |
| frontal cortex | UBERON:0001870 | 43.99 | silver quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 43.47 | gold quality |
| cerebral cortex | UBERON:0000956 | 43.19 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 42.31 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 41.35 | gold quality |
| Ammon’s horn | UBERON:0001954 | 40.74 | gold quality |
| duodenum | UBERON:0002114 | 39.28 | gold quality |
| right frontal lobe | UBERON:0002810 | 39.13 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 37.87 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 36.76 | gold quality |
| primary visual cortex | UBERON:0002436 | 36.24 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| sural nerve | UBERON:0015488 | 35.38 | gold quality |
| vermiform appendix | UBERON:0001154 | 34.80 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| mucosa of stomach | UBERON:0001199 | 33.20 | gold quality |
| lymph node | UBERON:0000029 | 32.30 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.30 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | cenpv | ENSDARG00000092285 |
| caenorhabditis_elegans | WBGENE00017771 |
Paralogs (3): CENPV (ENSG00000166582), CENPVL3 (ENSG00000224109), CENPVL2 (ENSG00000283093)
Protein
Protein identifiers
Centromere protein V-like protein 1 — A0A0U1RR11 (reviewed: A0A0U1RR11)
Alternative names: Centromere protein V pseudogene 1
All UniProt accessions (1): A0A0U1RR11
UniProt curated annotations — full annotation on UniProt →
Cofactor. Binds 2 Zn(2+) ions per subunit.
Similarity. Belongs to the Gfa family.
RefSeq proteins (1): NP_001342206* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR006913 | CENP-V/GFA | Domain |
| IPR011057 | Mss4-like_sf | Homologous_superfamily |
| IPR052355 | CENP-V-like | Family |
Pfam: PF04828
UniProt features (14 total): binding site 7, region of interest 3, compositionally biased region 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A0U1RR11-F1 | 70.33 | 0.31 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (7): 159; 162; 201; 204; 137; 139; 157
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 3 (showing top):
GOMF_CARBON_SULFUR_LYASE_ACTIVITY, chrXp11, GOMF_LYASE_ACTIVITY
GO Biological Process (0):
GO Molecular Function (2): carbon-sulfur lyase activity (GO:0016846), metal ion binding (GO:0046872)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| lyase activity | 1 |
| cation binding | 1 |
Protein interactions and networks
STRING
90 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CENPVL1 | GSPT2 | Q8IYD1 | 662 |
| CENPVL1 | MAGED1 | Q9Y5V3 | 516 |
| CENPVL1 | SHROOM4 | Q9ULL8 | 507 |
| CENPVL1 | FAM120C | Q9NX05 | 480 |
| CENPVL1 | TSPYL2 | Q9H2G4 | 419 |
| CENPVL1 | IQSEC2 | Q5JU85 | 416 |
| CENPVL1 | PHF8 | Q9UPP1 | 322 |
| CENPVL1 | KDM5C | P41229 | 280 |
| CENPVL1 | SLFN12 | Q8IYM2 | 263 |
| CENPVL1 | HUWE1 | Q7Z6Z7 | 259 |
| CENPVL1 | ACOT9 | Q9Y305 | 251 |
| CENPVL1 | CDCA3 | Q99618 | 247 |
| CENPVL1 | MEI4 | A8MW99 | 245 |
| CENPVL1 | CENPQ | Q7L2Z9 | 242 |
| CENPVL1 | MTRFR | Q9H3J6 | 223 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A0U1RR11, A0A0U1RRI6, A6NCS6, A6NJG2, B0BN44, D3YXK1, E9PY61, E9Q0B3, F5H4A9, O00220, O00221, P09038, P0DPI3, P22083, P98077, Q08AU9, Q2M2W7, Q2M3V2, Q2TBI2, Q5F267, Q5FW56, Q5IS69, Q5R866, Q5T4W7, Q5TM52, Q5U4P2, Q5VTJ3, Q659K9, Q673H1, Q69ZB3, Q6AYE8, Q6IPT2, Q6PJ61, Q7RTU4, Q7TSX9, Q7YR31, Q80SU3, Q86SH2, Q86Y97, Q8NBR0
Diamond homologs: A0A0U1RR11, A0A0U1RRI6, E1VBT6, P0DPI3, Q7Z7K6, Q9CXS4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
5 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 2 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
133 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:51710633:TCC:T | donor_gain | 0.5500 |
| X:51711162:C:CA | acceptor_gain | 0.4800 |
| X:51711530:T:TA | donor_gain | 0.4600 |
| X:51711531:A:AA | donor_gain | 0.4600 |
| X:51711551:ATTCG:A | donor_gain | 0.4600 |
| X:51711627:GTT:G | acceptor_gain | 0.4600 |
| X:51710832:G:GT | donor_gain | 0.4400 |
| X:51710672:G:GA | donor_gain | 0.4300 |
| X:51711000:G:GT | donor_gain | 0.4300 |
| X:51711626:A:AG | acceptor_gain | 0.4300 |
| X:51711627:G:GG | acceptor_gain | 0.4300 |
| X:51711553:TCG:T | donor_loss | 0.4200 |
| X:51711554:CGG:C | donor_loss | 0.4200 |
| X:51711555:GGTA:G | donor_loss | 0.4200 |
| X:51711556:G:GC | donor_loss | 0.4200 |
| X:51711557:T:A | donor_loss | 0.4200 |
| X:51711223:G:GT | donor_gain | 0.4100 |
| X:51711558:AAG:A | donor_loss | 0.4000 |
| X:51711128:TGCA:T | donor_gain | 0.3700 |
| X:51711129:GCAG:G | donor_gain | 0.3700 |
| X:51711167:AC:A | acceptor_gain | 0.3600 |
| X:51710670:GTGGC:G | donor_gain | 0.3500 |
| X:51710671:TGGCT:T | donor_gain | 0.3500 |
| X:51710673:GCTGG:G | donor_gain | 0.3500 |
| X:51711561:G:GT | donor_gain | 0.3500 |
| X:51711168:C:G | acceptor_gain | 0.3400 |
| X:51711623:TACA:T | acceptor_gain | 0.3400 |
| X:51711624:ACAG:A | acceptor_gain | 0.3400 |
| X:51711055:G:GT | donor_gain | 0.3300 |
| X:51711182:ACT:A | acceptor_gain | 0.3300 |
AlphaMissense
1741 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:51711109:T:C | F200L | 0.999 |
| X:51711111:C:A | F200L | 0.999 |
| X:51711111:C:G | F200L | 0.999 |
| X:51710941:T:C | F144L | 0.998 |
| X:51710943:T:A | F144L | 0.998 |
| X:51710943:T:G | F144L | 0.998 |
| X:51711041:T:C | F177S | 0.998 |
| X:51711136:T:C | F209L | 0.998 |
| X:51711138:C:A | F209L | 0.998 |
| X:51711138:C:G | F209L | 0.998 |
| X:51710942:T:C | F144S | 0.997 |
| X:51711133:A:C | S208R | 0.996 |
| X:51711135:T:A | S208R | 0.996 |
| X:51711135:T:G | S208R | 0.996 |
| X:51710942:T:G | F144C | 0.995 |
| X:51710908:C:G | H133D | 0.994 |
| X:51710927:G:A | C139Y | 0.994 |
| X:51711020:T:C | F170S | 0.994 |
| X:51711040:T:C | F177L | 0.994 |
| X:51711042:C:A | F177L | 0.994 |
| X:51711042:C:G | F177L | 0.994 |
| X:51711113:G:A | C201Y | 0.994 |
| X:51711121:T:A | C204S | 0.994 |
| X:51711122:G:C | C204S | 0.994 |
| X:51711137:T:C | F209S | 0.994 |
| X:51710820:G:C | W103C | 0.993 |
| X:51710820:G:T | W103C | 0.993 |
| X:51710920:T:C | C137R | 0.993 |
| X:51710936:T:A | V142D | 0.993 |
| X:51711125:G:A | G205E | 0.993 |
dbSNP variants (sampled 94 via entrez): RS1557347401 (X:51710365 G>C), RS1557347402 (X:51710374 A>G), RS1557347405 (X:51710416 G>T), RS1557347407 (X:51710521 G>C), RS1557347409 (X:51710546 G>T), RS1557347411 (X:51710552 G>C), RS1557347412 (X:51710560 C>A), RS1557347414 (X:51710564 C>T), RS1557347416 (X:51710669 G>A,C), RS1557347420 (X:51710690 G>C), RS1557347423 (X:51710700 C>G), RS1557347425 (X:51710708 G>C), RS1557347426 (X:51710730 A>G), RS1557347427 (X:51710752 A>C), RS1557347430 (X:51710753 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| butyraldehyde | increases expression | 1 |
| Valproic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.